A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study

Peer Review reports

Original Submission
10 Sep 2021	Submitted	Original manuscript
24 Dec 2021	Reviewed	Reviewer Report
28 Dec 2021	Reviewed	Reviewer Report
30 Dec 2021	Reviewed	Reviewer Report
4 Feb 2022	Author responded	Author comments - Armeen Mahvash
Resubmission - Version 2
4 Feb 2022	Submitted	Manuscript version 2
12 Feb 2022	Reviewed	Reviewer Report
24 Feb 2022	Reviewed	Reviewer Report
8 Mar 2022	Author responded	Author comments - Armeen Mahvash
Resubmission - Version 3
8 Mar 2022	Submitted	Manuscript version 3
Publishing
9 Mar 2022	Editorially accepted
28 Mar 2022	Article published	10.1186/s12876-022-02204-1

Back to article page